Close
ACHEMA MIDDLE EAST 2026

Usual Pharma Compliance Issues Noted In FDA Warning Letters

According to a study of the reasons behind warning letters sent by the US Food and Drug Administration Center for Drug Evaluation and Research and Center for...

CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23

Due to challenges in export sales in the regulated markets and a large base effect in the home formulations sector, the Indian pharmaceutical industry...

US Gives Lynparza Priority Review If Paired With Abiraterone

Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to...

NHS To Offer Variant-Busting Booster Before The Winters

The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in...

Evidence Shows Alzheimer Benefits From Genuv Cancer Drug

Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective...

Auvelity- A Possible Game Depression Treatment, Says Axsome

It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with...

Vaccine Cos Brace For Busy Months As Fear Of Influenza Looms

Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...